Fair short term price

UBS came out today with a re-rating price of $28.75 and we have others citing a mid teens to $20 range- so clearly it is anyone's guess and what is a fair PE multiple weighting. My science is simple- if you look at the SRX chart, you would have noticed that for 3 months between Nov14 and end of Jan15, SRX trade range between $26-29 but mainly around the $26-27 region. It was only when the profit season started in Feb that the price rocketed driven by solid half year results but mainly momentum driven by the great expectation of 1st line treatment fuelled by countless of broker re-pricing. So if we remove all that great expectations that began in Feb, everyone was happy buying and selling at $26 for a long 3 month period, why are we not happy to pay up to that price now given that the announcement has changed nothing in respect of continued BAU salvage therapy growth? To me, that where IMO the price will settle I. E $26-27 before the start of a consolidation pattern which will then be further and subsequently determined by developments in May/June.

In Your Money your Share segment today on Skynews Michael Heffernan also expressed confidence with a Hold call (for those invested) until the next results/ announcement.